While immunotherapies have transformed cancer treatment, they only benefit a subset of patients, with many failing to respond or quickly developing resistance. This Keystone Symposia will examine the limitations of immunotherapies, the reasons for failure and mechanisms of resistance, in order to guide strategies to overcome these hurdles and improve clinical outcomes.